Study finds new clues in understanding relapse in breast cancer

    Source: Xinhua| 2018-09-06 06:52:33|Editor: Yamei
    Video PlayerClose

    CHICAGO, Sept. 5 (Xinhua) -- A genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to U.S. researchers.

    The researchers at Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia analyzed tumor samples from more than 2,500 patients with estrogen receptor positive breast cancer, one of the most common forms of the disease.

    They found that although mutations in DDR1 and NF1 are rare, they are associated with early relapse, which makes them much more common in patients who unfortunately die from the disease.

    One unique element of the study was the age of the samples. Many were over 20 years old, allowing the researchers to know the full history of how the patients fared.

    The study also confirmed past work showing that relatively common mutations in genes called MAP3K1 and TP53 had opposite effects on tumor aggressiveness. Patients with MAP3K1 mutations did well, while those with TP53 mutations were likely to have a recurrence.

    The study has identified three genes, namely DDR1, PIK3R1 and NF1, with relatively uncommon mutations that were associated with cancer recurrence and spreading.

    "We would like to help doctors identify patients who are likely to do well versus those who are likely to have a recurrence," said first author Obi L. Griffith, an assistant professor of medicine and an assistant director of the McDonnell Genome Institute at Washington University School of Medicine.

    "Those with mutations that are associated with a good prognosis may need less intensive therapy than they might otherwise receive. But if a patient's tumor has mutations linked to high risk of relapse, it's useful to know that early so they can be treated with more aggressive therapies or even potential investigational therapies that could be targeted to their specific mutations," Griffith added.

    The researchers also pointed out the importance of continuing to sequence cancer genomes.

    More than 266,000 women in the United States are diagnosed with invasive breast cancer each year, according to the American Cancer Society, and about 70 percent of cases are estrogen receptor positive.

    The study was published on Tuesday in the journal Nature Communications.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011103261374478871
    主站蜘蛛池模板: 国内精品卡1卡2卡区别| 鲁啊鲁在线视频免费播放| 日本成人在线网址| 亚洲视频免费播放| 超污视频在线看| 国产香蕉在线精彩视频| 中文字幕乱妇无码AV在线 | 国产麻豆91网在线看| 亚洲人成精品久久久久| 香港黄色碟片黄色碟片| 国外免费直播性xxxx18| 中文亚洲av片不卡在线观看| 最近中文字幕国语免费高清6| 国产一级特黄高清免费下载| 2020亚洲欧美日韩在线观看| 好男人www社区视频在线| 久久久久国产一区二区| 狼色视频在线观免费观看| 国产精品久久久久一区二区三区| 久久久亚洲欧洲日产国码aⅴ| 欧美日韩精品久久久免费观看| 又紧又大又爽精品一区二区| 香蕉视频一区二区三区| 国产精品夜间视频香蕉| a级毛片免费看| 日韩精品视频在线播放| 亚洲精品国产高清嫩草影院| 91手机视频在线| 国产高清免费的视频| 一本一本久久a久久精品综合麻豆| 日本免费电影一区| 亚洲av无码一区二区三区在线播放 | 精品国产AV色欲果冻传媒| 国产在线精品网址你懂的| 一个人看日本www| 欧美国产伦久久久久| 你懂的视频在线| 羞羞答答www网址进入在线观看| 国产大尺度吃奶无遮无挡网| 一边摸边吃奶边做爽动态| 日本道精品一区二区三区|